Peter Sebo Selected Research

Peter Sebo Research Topics

Disease

32	Whooping Cough (Pertussis) 09/2023 - 10/2003
21	Infections 01/2022 - 04/2003
6	Tuberculosis (Tuberculoses) 01/2012 - 05/2005
5	Neoplasms (Cancer) 04/2016 - 01/2006
4	Malaria 03/2013 - 04/2006
2	Latent Tuberculosis 01/2023 - 05/2005
2	Disease Progression 01/2017 - 01/2016
2	Starvation 12/2006 - 02/2005
1	Pneumonia (Pneumonitis) 01/2022
1	Cough 08/2021
1	Sneezing 08/2021
1	Atrophic Rhinitis (Ozena) 01/2020
1	Edema (Dropsy) 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2018
1	Pathologic Processes 12/2016
1	Bordetella Infections 10/2014
1	Melanoma (Melanoma, Malignant) 08/2014
1	Communicable Diseases (Infectious Diseases) 08/2014
1	Human Influenza (Influenza) 01/2013
1	Pleuropneumonia 01/2012
1	Celiac Disease (Celiac Sprue) 04/2011
1	Wasting Syndrome (Wasting Disease) 12/2009
1	Pulmonary Tuberculosis 07/2007
1	HIV Infections (HIV Infection) 07/2007
1	Hypersensitivity (Allergy) 05/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2006
1	Hemolysis 02/2006
1	Bovine Tuberculosis 11/2004

Drug/Important Bio-Agent (IBA)

22	Adenylate Cyclase ToxinIBA 09/2023 - 10/2003
16	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2003
14	AntigensIBA 01/2021 - 11/2004
12	Hemolysin Proteins (Hemolysins)IBA 09/2023 - 10/2014
12	VaccinesIBA 01/2022 - 01/2012
11	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2022 - 11/2004
8	Virulence Factors (Pathogenicity Factors)IBA 10/2022 - 10/2003
7	ToxoidsIBA 01/2022 - 05/2005
5	Hemagglutinins (Hemagglutinin)IBA 10/2022 - 01/2013
5	Complement Receptors (Complement Receptor)IBA 01/2021 - 12/2015
4	IntegrinsIBA 10/2022 - 12/2015
4	AntibodiesIBA 01/2022 - 12/2009
3	EnzymesIBA 01/2020 - 01/2017
3	Subunit VaccinesIBA 03/2013 - 04/2006
3	EpitopesIBA 11/2008 - 04/2006
3	Tuberculin (PPD)IBA 07/2007 - 05/2005
2	BCG Vaccine FDA Link 01/2023 - 05/2005
2	Pertussis ToxinIBA 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 10/2021 - 02/2006
2	Acellular VaccinesIBA 01/2021 - 01/2020
2	Adenosine Monophosphate (AMP)IBA 01/2019 - 01/2017
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2017 - 01/2016
2	Indicators and Reagents (Reagents)IBA 12/2016 - 05/2005
2	ProteomeIBA 03/2016 - 12/2006
2	Type III Secretion SystemsIBA 08/2013 - 11/2008
2	IronIBA 12/2006 - 02/2005
2	CytokinesIBA 05/2006 - 02/2006
1	MucinsIBA 08/2021
1	AerosolsIBA 08/2021
1	pertactin FDA Link 01/2021
1	2,6-dinitrotoluene (DNT)IBA 01/2020
1	CarbonIBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2019
1	Macrophage Colony-Stimulating FactorIBA 01/2019
1	Pertussis VaccineIBA 10/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Cyclic AMP (AMP, Cyclic)IBA 01/2017
1	Histocompatibility Antigens Class IIIBA 01/2017
1	LigandsIBA 04/2016
1	Dendrimers (Dendrons)IBA 04/2016
1	Interleukin-10 (Interleukin 10)IBA 10/2014
1	Interleukin-12 (IL 12)IBA 10/2014
1	Neutralizing AntibodiesIBA 03/2013
1	Antiparasitic Agents (Antiparasitics)IBA 03/2013
1	Malaria VaccinesIBA 04/2012
1	Protein Subunits (Protein Subunit)IBA 01/2012
1	CalciumIBA 01/2012
1	GliadinIBA 04/2011
1	InflammasomesIBA 08/2010
1	Capsid Proteins (Capsid Protein)IBA 12/2009
1	Interferon-gamma (Interferon, gamma)IBA 07/2007
1	alpha-Crystallins (alpha-Crystallin)IBA 07/2007
1	Mycobacterium tuberculosis antigensIBA 07/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006
1	CTLA-4 AntigenIBA 04/2006
1	CationsIBA 02/2006
1	Interleukin-6 (Interleukin 6)IBA 02/2006
1	InterleukinsIBA 02/2006
1	CD18 AntigensIBA 02/2006
1	Oncogene Proteins (Oncogene Protein)IBA 01/2006

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2023
1	Surgical Instruments (Clip) 01/2020
1	Immunotherapy 01/2006